|
|
Volumn 23, Issue 26, 2005, Pages 6283-6284
|
|
Individualizing therapy for the hematologic malignancies: The stuff of genes and dreams
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
CYCLOPHOSPHAMIDE;
DEXAMETHASONE;
DOXORUBICIN;
ETOPOSIDE;
IMATINIB;
IMMUNOMODULATING AGENT;
MELPHALAN;
PREDNISONE;
PROTEINASE INHIBITOR;
RETINOIC ACID;
RITUXIMAB;
THALIDOMIDE;
TUMOR MARKER;
VINCRISTINE;
CANCER CLASSIFICATION;
CANCER DIAGNOSIS;
CANCER RESEARCH;
CANCER THERAPY;
CHRONIC MYELOID LEUKEMIA;
COMBINATION CHEMOTHERAPY;
DNA MICROARRAY;
EDITORIAL;
GENE EXPRESSION PROFILING;
HEMATOLOGIC MALIGNANCY;
HUMAN;
IMAGING;
IMMUNOPHENOTYPING;
IMMUNOTHERAPY;
LEUKEMIA;
LYMPHOMA;
MEDICAL PRACTICE;
MYELOMA;
NONHODGKIN LYMPHOMA;
PHILADELPHIA 1 CHROMOSOME;
PRIORITY JOURNAL;
BLOOD DISEASE;
COMPARATIVE STUDY;
FEMALE;
FORECASTING;
GENE THERAPY;
GENE TRANSFER;
GENETICS;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
MALE;
MORTALITY;
PATIENT CARE;
PATIENT CARE PLANNING;
STANDARD;
SURVIVAL;
TREATMENT OUTCOME;
FEMALE;
FORECASTING;
GENE THERAPY;
GENE TRANSFER TECHNIQUES;
HEMATOLOGIC NEOPLASMS;
HEMATOPOIETIC STEM CELL TRANSPLANTATION;
HUMANS;
MALE;
PATIENT CARE PLANNING;
PATIENT-CENTERED CARE;
SURVIVAL ANALYSIS;
TREATMENT OUTCOME;
|
|
EID: 27244442735
PISSN: 0732183X
EISSN: None
Source Type: Journal
DOI: 10.1200/JCO.2005.08.005 Document Type: Editorial |
|
Times cited : (3)
|
|
References (11)
|
